
Hem/Onc Board Review
@hemoncq
Hematology/oncology board review style questions. By @ahmadalhader and @DrM_AbuZaid
ID: 1315371414766211077
11-10-2020 19:19:50
741 Tweet
1,1K Followers
493 Following


I am pleased to share this article written with my colleague Fawzi Abu Rous, MD, in which we share our experiences as IMG during the COVID-19 pandemic cc Aakash Desai, MD, MPH, FASCO tandfonline.com/doi/full/10.10…


🔗 tandfonline.com/eprint/ICTXC7N… IMG Oncologists Hem-Onc Fellows Network ECFMG J-1 Visa Sponsorship Inas Abuali, MD Ana I. Velázquez Mañana, MD, MSc, FASCO Andrea Anampa-Guzmán (she/ella) Henry Ford Hematology/Oncology Fellowship Zaid Abdel-Rahman Samer Al Hadidi, MD,MS,FACP Rahul Banerjee, MD, FACP Faisal, Salman M Yan Leyfman, MD Rebecca Chacko @esinghimd @drRTee




Help us in filling this survey and spreading the word👇 ✅Link: redcap.ccf.org/redcap/surveys… #leusm #lymsm #mmsm #hemeTwitter #hemepath Hem-Onc Fellows Network Aaron Goodman - “Papa Heme” Manni Mohyuddin Amar Kelkar, MD, MPH, FACP Eddie Cliff IMG Oncologists OncoAlert Hem/Onc Board Review UAMS Hemepath UAMS Pathology David Steensma, MD


☣️ Rare but life-threatening irAEs can have a lasting impact on our patients. #OncTwitter, how do you strike a balance between effectively obtaining IO consent & communicating potential serious irAEs to patients without undue distress? H. Jack West, MD, FASCO Jarushka Naidoo Jill Feldman


My future boss MSK Department of Medicine, Dr. Deborah Schrag, now taking the stage to present the results of the PROSPECT trial evaluating chemoradiation vs FOLFOX for locally advanced rectal cancer. ASCO #ASCO23 Memorial Sloan Kettering Cancer Center OncoAlert HemOnc Today Hem-Onc Fellows Network Hem/Onc Board Review


Now Roy Herbst with the third presentation of the plenary session with the #ADAURA study. Now with an overall survival benefit with osimertinib in patients with EGFR+ NSCLC. ASCO #ASCO23 Yale Cancer Center Yale School of Medicine IMG Oncologists OncoAlert HemOnc Today Hem-Onc Fellows Network


We are very excited to welcome our new class of fellows matched Indiana University Hematology/Oncology Fellowship Congratulations! We are THRILLED to have you join us and looking forward to welcoming all of you! IU Simon Comprehensive Cancer Center


We are back this week with Tom Powles & Brian Rini, MD diving into metastatic RCC! We discuss risk stratification, their differing opinions around cytoreductive nephrectomy, 1L tx & sequencing, pearls regarding sarcomatoid, non-clear-cell RCC & tips for trainees Uromigos




Our fellow Ahmed Bilal Khalid recently attended the ASCR/ASCO Methods in Clinical Cancer Research Workshop to continue developing a clinical trial with our excellent GU faculty. Way to go!

Our fellow Noah Richardson attended the AACR Molecular Biology in Clinical Oncology workshop, focused on molecular biology, translational cancer research, career development, and grant writing for the aspiring physician-scientist. Congrats! IU Simon Comprehensive Cancer Center




Congrats to chief fellow Noah Richardson for their Conquer Cancer, the ASCO Foundation Young Investigator Award investigating novel prostate cancer therapeutics and our brilliant faculty member Misty Dawn Shields Career Development Award in lung cancer. #ASCO2025 is off to a great start! IU Simon Comprehensive Cancer Center


Proud to be an investigator in the head and neck cohort of SGN35-033. Our data was discussed today at ASCO, showing promising clinical efficacy of BV + Pembro in treatment -naive patients with metastatic HNSCC and CPS ≥1. meetings.asco.org/abstracts-pres… Nebraska Medicine UNMC Heme Onc
